Three hits with further updside | Praemium making hay while the sun shines
General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.
About this video
Investor Mutual's Simon Conn says it was a pleasing reporting season, considering businesses appear to be getting back on track after years of disruption. He names three stocks in the portfolio which performed well in the half, with further upside to come. Listen for his views on A2B (A2B), GUD Holdings (GUD) and Australian Clinical Labs (ACL)
Praemium reported well for the half with EBITDA up 52% to $11.4m and revenue up 17%. CEO Anthony Wamsteker explains the strategy going forward, and weighs-in on whether Praemium will be the acquirer or acquiree.
More like this
11:02
the openThree small caps to watch as rates peakWednesday5:56
Market Wrap | Tabcorp, Treasury Wine Estates, Peter Warren Automotive, Lendlease, Challenger, Maas Group, Praemium, PYC Therapeutics, Artrya2 Oct 2026 · CGF, LLC, TAH, TWE4:42
Market Update | Challenger, Maas Group, Praemium, PYC Therapeutics, Tabcorp, Treasury Wine Estates, Peter Warren Automotive, Artrya2 Oct 2026 · CGF, TAH, TWE3:27
Market Update | Micron Technology, Accenture, Challenger, Maas Group, Praemium, PYC Therapeutics, Artrya2 Oct 2026 · CGF